×
Natera Cash on Hand 2014-2024 | NTRA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Natera cash on hand for the quarter ending September 30, 2024 was
$0.922B
, a
1.52% decline
year-over-year.
Natera cash on hand for 2023 was
$0.879B
, a
2.16% decline
from 2022.
Natera cash on hand for 2022 was
$0.898B
, a
1.76% decline
from 2021.
Natera cash on hand for 2021 was
$0.915B
, a
24.01% increase
from 2020.
View More
Natera Cash on Hand 2014-2024 | NTRA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Natera cash on hand for 2023 was
$0.879B
, a
2.16% decline
from 2022.
Natera cash on hand for 2022 was
$0.898B
, a
1.76% decline
from 2021.
Natera cash on hand for 2021 was
$0.915B
, a
24.01% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$91.4B
Cencora (COR)
$47.5B
DiDi Global (DIDIY)
$23.3B
ICON (ICLR)
$16.1B
Viatris (VTRS)
$15.6B
Avantor (AVTR)
$13.4B
Revvity (RVTY)
$13.4B
CochLear (CHEOY)
$12.8B
BioMerieux (BMXMF)
$12.7B
Solventum (SOLV)
$11.6B
Medpace Holdings (MEDP)
$9.8B
Doximity (DOCS)
$9.6B
Charles River Laboratories (CRL)
$9.5B
HealthEquity (HQY)
$9B
Sonic Healthcare (SKHHY)
$8.8B
Bausch + Lomb (BLCO)
$6.9B
Life Times (LTH)
$5.1B
Sotera Health (SHC)
$3.9B
Organon (OGN)
$3.8B
BrightSpring Health Services (BTSG)
$3.2B
Surgery Partners (SGRY)
$2.9B
PACS (PACS)
$2.6B
Concentras Parent (CON)
$2.6B
Ardent Health Partners (ARDT)
$2.4B
Premier (PINC)
$2.1B
Alignment Healthcare (ALHC)
$2.1B
Ryman Healthcare (RYHTY)
$2B
GeneDx Holdings (WGS)
$2B
GoodRx Holdings (GDRX)
$1.6B
Teladoc Health (TDOC)
$1.5B